Axsome Therapeutics (AXSM) had the highest return between December 1, 2018 and March 31, 2019 by a mid-cap US stock, returning 331.2%.
| ASSET | DATE | % RETURN |
|---|---|---|
Axsome Therapeutics (AXSM) | 12/1/2018 - 3/31/2019 | 331.21% |
CleanSpark (CLSK) | 12/1/2018 - 3/31/2019 | 130.46% |
Guardant Health (GH) | 12/1/2018 - 3/31/2019 | 108.99% |
Veracyte (VCYT) | 12/1/2018 - 3/31/2019 | 100.16% |
Catalyst Pharmaceuticals (CPRX) | 12/1/2018 - 3/31/2019 | 88.19% |
Protagonist Therapeutics (PTGX) | 12/1/2018 - 3/31/2019 | 85.4% |
YETI (YETI) | 12/1/2018 - 3/31/2019 | 75.67% |
Companhia Siderurgica Nacional ADR (SID) | 12/1/2018 - 3/31/2019 | 72.69% |
Riot Blockchain (RIOT) | 12/1/2018 - 3/31/2019 | 69.43% |
StoneCo (STNE) | 12/1/2018 - 3/31/2019 | 68.97% |
Enphase Energy (ENPH) | 12/1/2018 - 3/31/2019 | 65.41% |
Universal Display (OLED) | 12/1/2018 - 3/31/2019 | 61.3% |
Sibanye Gold Ltd ADR (SBSW) | 12/1/2018 - 3/31/2019 | 60.7% |
Eldorado Gold (EGO) | 12/1/2018 - 3/31/2019 | 59.66% |
TG Therapeutics (TGTX) | 12/1/2018 - 3/31/2019 | 56.42% |
MAG Silver (MAG) | 12/1/2018 - 3/31/2019 | 53.82% |
Griffon (GFF) | 12/1/2018 - 3/31/2019 | 52.22% |
New Oriental Education & Technology (EDU) | 12/1/2018 - 3/31/2019 | 51.03% |
Osisko Gold Ro (OR) | 12/1/2018 - 3/31/2019 | 48.8% |
Zai Lab (ZLAB) | 12/1/2018 - 3/31/2019 | 47.7% |
Frontdoor (FTDR) | 12/1/2018 - 3/31/2019 | 47.09% |
Aris Mining (ARMN) | 12/1/2018 - 3/31/2019 | 43.44% |
Match (MTCH) | 12/1/2018 - 3/31/2019 | 43.29% |
Stride (LRN) | 12/1/2018 - 3/31/2019 | 42.09% |
CLARIVATE (CLVT) | 12/1/2018 - 3/31/2019 | 40.44% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
